These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20185770)

  • 1. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action.
    Ferrara N
    Mol Biol Cell; 2010 Mar; 21(5):687-90. PubMed ID: 20185770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.
    Vempati P; Popel AS; Mac Gabhann F
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):1-19. PubMed ID: 24332926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
    Park JE; Keller GA; Ferrara N
    Mol Biol Cell; 1993 Dec; 4(12):1317-26. PubMed ID: 8167412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial distribution of VEGF isoforms and chemotactic signals in the vicinity of a tumor.
    Small AR; Neagu A; Amyot F; Sackett D; Chernomordik V; Gandjbakhche A
    J Theor Biol; 2008 Jun; 252(4):593-607. PubMed ID: 18395755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis.
    Vempati P; Popel AS; Mac Gabhann F
    BMC Syst Biol; 2011 May; 5():59. PubMed ID: 21535871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.
    Lee S; Jilani SM; Nikolova GV; Carpizo D; Iruela-Arispe ML
    J Cell Biol; 2005 May; 169(4):681-91. PubMed ID: 15911882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).
    Byrne AM; Bouchier-Hayes DJ; Harmey JH
    J Cell Mol Med; 2005; 9(4):777-94. PubMed ID: 16364190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release.
    Goerges AL; Nugent MA
    J Biol Chem; 2004 Jan; 279(3):2307-15. PubMed ID: 14570917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the chimeric plasmin-resistant VEGF165/VEGF183 (132-158) protein in murine breast cancer induces distinct vascular patterning adjacent to tumors and retarded tumor growth.
    Zhang HY; Fan BL; Wu XS; Mu LM; Wang WF; Zhu WL
    Mol Med Rep; 2015 Feb; 11(2):1483-9. PubMed ID: 25373557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.
    Hawinkels LJ; Zuidwijk K; Verspaget HW; de Jonge-Muller ES; van Duijn W; Ferreira V; Fontijn RD; David G; Hommes DW; Lamers CB; Sier CF
    Eur J Cancer; 2008 Sep; 44(13):1904-13. PubMed ID: 18691882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
    Hashimoto G; Inoki I; Fujii Y; Aoki T; Ikeda E; Okada Y
    J Biol Chem; 2002 Sep; 277(39):36288-95. PubMed ID: 12114504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
    Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
    Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study.
    Krilleke D; Ng YS; Shima DT
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1201-6. PubMed ID: 19909247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.
    Ehrbar M; Djonov VG; Schnell C; Tschanz SA; Martiny-Baron G; Schenk U; Wood J; Burri PH; Hubbell JA; Zisch AH
    Circ Res; 2004 Apr; 94(8):1124-32. PubMed ID: 15044320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
    Poltorak Z; Cohen T; Neufeld G
    Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.
    Chen TT; Luque A; Lee S; Anderson SM; Segura T; Iruela-Arispe ML
    J Cell Biol; 2010 Feb; 188(4):595-609. PubMed ID: 20176926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor isoforms in the Japanese quail embryo.
    Finkelstein EB; Poole TJ
    Growth Factors; 2003 Mar; 21(1):41-9. PubMed ID: 12795335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].
    Fan SJ; He SZ
    Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast-derived matrix (FDM) as a novel vascular endothelial growth factor delivery platform.
    Du P; Hwang MP; Noh YK; Subbiah R; Kim IG; Bae SE; Park K
    J Control Release; 2014 Nov; 194():122-9. PubMed ID: 25194780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.